Ultragenyx Pharmaceutical Inc. ·
RARE 8-K 2026-09-17
Ultragenyx Pharmaceutical Inc. (RARE) 8-K dated 2026-09-17 — accession 0001515673-26-000006.
Ultragenyx Pharmaceutical Inc. (RARE) is a biotechnology company listed on US.
Ultragenyx Pharmaceutical Inc. filed a 8-K on 2026-09-17. Accession 0001515673-26-000006.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported RARE revenue for 2025-12-31 was $673.0M. Net income was -$575.0M. Revenue was up 20.1% from 2024-12-31 to 2025-12-31. RARE currently screens at market cap $2.79B.
Not investment advice. The RARE SEC hub lists recent forms. The stock page is the research view.